ロード中...
The potential of cannabidiol in the COVID‐19 pandemic
Identifying drugs effective in the new coronavirus disease 2019 (COVID‐19) is crucial, pending a vaccine against SARS‐CoV2. We suggest the hypothesis that cannabidiol (CBD), a non‐psychotropic phytocannabinoid, has the potential to limit the severity and progression of the disease for several reason...
保存先:
| 出版年: | Br J Pharmacol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300643/ https://ncbi.nlm.nih.gov/pubmed/32519753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15157 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|